I'm working with a group of investors who, in turn, is looking for drug candidates as investment opportunities. The investors would invest in the development of the candidate itself (not the company) in exchange for various risk/reward sharing arrangements. It's an interesting model, blending venture capital techniques with drug development processes.
If you work for a pharmaceutical or biotechnology company, and have compounds (lead or back up) which are languishing due to a lack of funding, please let me know. I may be able to make the connection. Compounds from academia would also be considered if the data package is robust enough.
Comments